Genesis Drug Discovery & Development (GD3), a member of Genesis Biotechnology Group (GBG) has acquired Comparative Biosciences Inc. (CBI), a Contract Research Organization (CRO) located in Sunnyvale, California.   CBI is specialized in GLP (Good Laboratory Practice) Toxicology and Safety Pharmacology projects for IND-enabling research studies. This portfolio addition will enable GD3 to expand its pre-clinical services to GLP based studies by offering integrated, single-point-of-contact servi...